The White House has backed off its push for $5.6 billion in "mandatory"
funding for Project BioShield, the Bush Administration's plan to speed development
and production of new vaccines and therapeutics for bioweapons. The administration
dropped its insistence on guaranteeing funds after Sen Robert Byrd, (D, WVa),
held up legislation funding the Department of Homeland Security for fiscal
year 2004, which begins October 1. He and other lawmakers argued that providing
mandatory funding would create an "entitlement program" for pharmaceutical
Vastag B. Commission Wants Studies of ART Health Effects. JAMA. 2003;290(14):1844. doi:10.1001/jama.290.14.1844-a